Have your own idea? Try our Stock Screener
Japanese (NIKKEI) Life Sciences Industry Analysis
UpdatedAug 28, 2026
DataAggregated Company Financials
Companies13
- 7D-2.4%
- 3M4.4%
- 1Y-16.5%
- YTD-16.4%
Over the last 7 days, the Life Sciences industry has dropped 2.4%, driven by Shin Nippon Biomedical Laboratories declining 4.7%. The industry has fallen 16% in the last year. As for the next few years, earnings are expected to grow by 2.8% per annum.
Industry Valuation and Performance
Has the Japanese Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 28 Aug 2026 | JP¥122.1b | JP¥64.0b | JP¥1.1b | 18.6x | 110x | 1.9x |
| Sun, 26 Jul 2026 | JP¥113.1b | JP¥62.8b | JP¥631.5m | 23.7x | 179x | 1.8x |
| Tue, 23 Jun 2026 | JP¥105.0b | JP¥62.8b | JP¥599.2m | 24.1x | 175.2x | 1.7x |
| Thu, 21 May 2026 | JP¥119.8b | JP¥62.9b | JP¥617.6m | 25.2x | 194x | 1.9x |
| Sat, 18 Apr 2026 | JP¥145.8b | JP¥63.3b | -JP¥864,496,000.00 | 22.9x | -168.6x | 2.3x |
| Mon, 16 Mar 2026 | JP¥145.3b | JP¥63.2b | -JP¥944,048,000.00 | 22.3x | -153.9x | 2.3x |
| Wed, 11 Feb 2026 | JP¥157.8b | JP¥63.4b | -JP¥612,692,000.00 | 24.8x | -257.6x | 2.5x |
| Fri, 09 Jan 2026 | JP¥153.7b | JP¥66.9b | JP¥72.2m | 21.8x | 2128.9x | 2.3x |
| Sun, 07 Dec 2025 | JP¥152.9b | JP¥67.6b | JP¥702.4m | 17.7x | 217.6x | 2.3x |
| Tue, 04 Nov 2025 | JP¥132.2b | JP¥66.5b | JP¥1.5b | 15.9x | 90.6x | 2x |
| Thu, 02 Oct 2025 | JP¥140.9b | JP¥66.5b | JP¥1.5b | 16.8x | 96.6x | 2.1x |
| Sat, 30 Aug 2025 | JP¥147.9b | JP¥66.5b | JP¥1.5b | 16.7x | 101.4x | 2.2x |
| Mon, 28 Jul 2025 | JP¥140.6b | JP¥66.0b | JP¥1.1b | 16.6x | 124.6x | 2.1x |
| Wed, 25 Jun 2025 | JP¥140.7b | JP¥66.0b | JP¥1.1b | 16.4x | 124.5x | 2.1x |
| Fri, 23 May 2025 | JP¥132.5b | JP¥66.0b | JP¥1.1b | 16.3x | 117x | 2x |
| Sun, 20 Apr 2025 | JP¥132.6b | JP¥63.8b | JP¥963.0m | 14.1x | 137.7x | 2.1x |
| Tue, 18 Mar 2025 | JP¥163.1b | JP¥64.8b | JP¥927.4m | 15.5x | 175.8x | 2.5x |
| Thu, 13 Feb 2025 | JP¥174.0b | JP¥65.3b | JP¥982.5m | 15.9x | 177.1x | 2.7x |
| Sat, 11 Jan 2025 | JP¥164.8b | JP¥62.0b | JP¥440.7m | 17.8x | 373.9x | 2.7x |
| Mon, 09 Dec 2024 | JP¥163.1b | JP¥62.0b | JP¥825.9m | 16.9x | 197.5x | 2.6x |
| Wed, 06 Nov 2024 | JP¥150.5b | JP¥61.5b | JP¥1.8b | 20.9x | 81.8x | 2.4x |
| Fri, 04 Oct 2024 | JP¥156.3b | JP¥61.5b | JP¥1.8b | 18x | 84.9x | 2.5x |
| Sun, 01 Sep 2024 | JP¥164.8b | JP¥61.5b | JP¥2.1b | 20.2x | 78.1x | 2.7x |
| Tue, 30 Jul 2024 | JP¥164.5b | JP¥61.8b | JP¥3.2b | 25x | 50.8x | 2.7x |
| Thu, 27 Jun 2024 | JP¥170.9b | JP¥61.8b | JP¥3.2b | 26.8x | 52.8x | 2.8x |
| Sat, 25 May 2024 | JP¥159.2b | JP¥61.8b | JP¥3.4b | 25x | 47.5x | 2.6x |
| Mon, 22 Apr 2024 | JP¥175.2b | JP¥62.3b | JP¥3.3b | 14.2x | 53.2x | 2.8x |
| Wed, 20 Mar 2024 | JP¥231.4b | JP¥155.4b | JP¥8.6b | 14x | 26.8x | 1.5x |
| Fri, 16 Feb 2024 | JP¥228.9b | JP¥156.2b | JP¥9.0b | 14.3x | 25.4x | 1.5x |
| Sun, 14 Jan 2024 | JP¥233.8b | JP¥167.1b | JP¥8.5b | 15.8x | 27.5x | 1.4x |
| Tue, 12 Dec 2023 | JP¥229.3b | JP¥167.4b | JP¥8.7b | 14.6x | 26.4x | 1.4x |
| Thu, 09 Nov 2023 | JP¥236.9b | JP¥168.0b | JP¥9.2b | 14.9x | 25.8x | 1.4x |
| Sat, 07 Oct 2023 | JP¥238.2b | JP¥179.3b | JP¥12.8b | 15.1x | 18.6x | 1.3x |
| Mon, 04 Sep 2023 | JP¥268.2b | JP¥179.3b | JP¥12.8b | 17x | 21x | 1.5x |
Price to Earnings Ratio
21x
Current Industry PE
- Investors are pessimistic on the Japanese Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 110x which is lower than its 3-year average PE of 183x.
- The 3-year average PS ratio of 2.1x is higher than the industry's current PS ratio of 1.9x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have declined 56% per year over the last three years,
- Revenues have also declined 29% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the Japanese Healthcare industry?
| JP Market | 1.23% | |
| Healthcare | -1.47% | |
| Life Sciences | -2.36% | |
| Clinical Research and Equipment | -2.36% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 4572 Carna Biosciences | JP¥423.00 | 5.0% +JP¥423.1m | 93.2% | PS12.3x | |
| 4570 Immuno-Biological Laboratories | JP¥1.11k | 2.8% +JP¥279.4m | 132.2% | PE28x | |
| 7707 Precision System Science | JP¥217.00 | 1.4% +JP¥82.4m | 5.9% | PE15.1x | |
| 4583 Chiome Bioscience | JP¥85.00 | 1.2% +JP¥78.9m | -38.0% | PS10.9x | |
| 6090 Human Metabolome Technologies | JP¥626.00 | 2.3% +JP¥77.9m | -13.4% | PE17.4x |